Literature DB >> 11672820

Genetic susceptibility in chronic viral hepatitis.

M Thursz1.   

Abstract

Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) may result in a number of different clinical outcomes. There is strong evidence in HBV infection that host genetic factors play a major role in determining the outcome of infection. A number of approaches may be used to determine the specific genetic factors involved but the principal method which has been used to date is the disease association study. Disease association studies have a number of drawbacks but trials with well-constructed designs and large numbers of cases have recently produced compelling and reproducible results. In particular alleles in the MHC class II loci and interleukin 10 promoter have been demonstrated to influence the outcome of these infections.

Entities:  

Mesh:

Year:  2001        PMID: 11672820     DOI: 10.1016/s0166-3542(01)00175-9

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  40 in total

1.  Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population.

Authors:  Xiuchan Guo; Yong Zhang; Ji Li; Jingchen Ma; Zuli Wei; Wenjie Tan; Stephen J O'Brien
Journal:  Hepatology       Date:  2011-01-04       Impact factor: 17.425

2.  Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota.

Authors:  Han-Hsuan Chou; Wei-Hung Chien; Li-Ling Wu; Chi-Hung Cheng; Chen-Han Chung; Jau-Haw Horng; Yen-Hsuan Ni; Hong-Tai Tseng; Dafei Wu; Xuemei Lu; Hurng-Yi Wang; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

3.  C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.

Authors:  M Tevfik Dorak; Gbolahan O Folayan; Santosh Niwas; Dirk J van Leeuwen; Leland J Yee; Jianming Tang; Richard A Kaslow
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients.

Authors:  Feng Lv; Yu-Feng Gao; Zhen-Huan Zhang; Tian-Chen Zhang; Fa-Ming Pan; Ming-Fang Cui; Shu-Ling Xia; Xu Li; Hua-Fa Yin
Journal:  World J Hepatol       Date:  2011-03-27

5.  No association between IRF3 polymorphism and susceptibility to hepatitis B virus infection in Chinese patients.

Authors:  Fang Yan; Yu-Feng Gao; Feng Lv; Tian-Chen Zhang; Xu Li; Hua-Fa Yin
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

6.  Effects of variant rs346473 in ARHGAP24 gene on disease progression of HBV infection in Han Chinese population.

Authors:  Lifeng Liu; Jinjian Yao; Jin Li; Jinliang Zhang; Jinling Yu; Xiaorui Jiang; Shuzhen Sun; Qing Liu; Ying Chang; Yongwen He; Jusheng Lin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

7.  Molecular mechanisms of HBeAg in persistent HBV infection.

Authors:  Li-Min Chen; Xue-Gong Fan; Jing Ma; Bo He; Yong-Fang Jiang
Journal:  Hepatol Int       Date:  2016-05-18       Impact factor: 6.047

8.  Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population.

Authors:  Lu Zhi-ming; Jiao Yu-lian; Feng Zhao-lei; Wu Chun-xiao; Dong Zhen-fang; Zhang Bing-chang; Zhao Yue-ran
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

9.  The association between three IL-6 polymorphisms and HBV-related liver diseases: a meta-analysis.

Authors:  Lei Chang; Tian Lan; Long Wu; Cuicui Li; Yufeng Yuan; Zhisu Liu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 10.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.